neuropathy semaglutide Wegovy may raise risk of ischemic optic ποΈ The obesity drug semaglutide, marketed as Wegovy, was associated with a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic Popular GLP-1 Weight Loss Drugs
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 1 - Sep 6





























